Not checked for notices yet.

The BCMA-Targeted Fourth-Generation CAR-T Cells Secreting IL-7 and CCL19 for Therapy of Refractory/Recurrent Multiple Myeloma

Deming Duan, Deming Duan, Keke Wang and 19 more

Frontiers in Immunology · 2021

doi:10.3389/fimmu.2021.609421

Cited by papers we hold 3

CAR T therapies in multiple myeloma: unleashing the future · 2024
No notice
CAR-T Cell Therapy in Hematological Malignancies: Current Opportunities and Challenges · 2022
No notice
Next generations of CAR-T cells - new therapeutic opportunities in hematology? · 2022
No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.